NewslettersHepatic Cell NewsUncategorizedHepatic IRF8 Expression Suppresses Hepatocellular Carcinoma Progression and Enhances the Response to Anti-PD-1 TherapyBy Justin.choi - January 7, 20220142Scientists identified interferon regulatory factor (IRF8) as an important prognostic biomarker in hepatocellular carcinoma patients which predicted the response and sensitivity to anti-PD-1 therapy.[Hepatology] 7992332 {7992332:EEEEEEEE} apa 50 1 170437 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract